AI assistant
Sending…
Vericel Corp — Director's Dealing 2010
Mar 15, 2010
31799_dirs_2010-03-15_f9921ddc-9a92-4752-ab64-c5135c7ef66e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AASTROM BIOSCIENCES INC (ASTM)
CIK: 0000887359
Period of Report: 2010-03-11
Reporting Person: ZERBE ROBERT L MD (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-03-11 | Stock Option (right to buy) | $1.52 | A | 45500 | Acquired | 2020-03-11 | Common Stock (45500) | Direct |
Footnotes
F1: These options vest in three equal annual installments beginning on the first anniversary of the grant date.
More from Vericel Corp
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 19
Proxy Solicitation & Information Statement
2026
Mar 19
Annual Report
2026
Mar 19